TuHURA Biosciences, Inc.
$2.83
▼
-12.96%
2026-04-21 07:23:01
www.tuhurabio.com
NCM: HURA
Explore TuHURA Biosciences, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$179.93 M
Current Price
$2.83
52W High / Low
$4.44 / $0.41
Stock P/E
—
Book Value
$0.35
Dividend Yield
0%
ROCE
-120.19%
ROE
-1.69%
Face Value
—
EPS
$-0.63
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
22
Beta
—
Debt / Equity
3.34
Current Ratio
0.78
Quick Ratio
0.78
Forward P/E
-3.91
Price / Sales
—
Enterprise Value
$141.68 M
EV / EBITDA
-5.05
EV / Revenue
—
Rating
None
Target Price
$8.62
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BioCardia, Inc. | $1.25 | — | $12.91 M | — | -843.83% | -9.5% | $3.2 / $1 | $0.08 |
| 2. | Vaxcyte, Inc. | $61.4 | — | $8.86 B | — | -33.02% | -25.59% | $65 / $28.09 | $20.49 |
| 3. | HCW Biologics Inc. | $0.41 | — | $2.94 M | — | -4764.31% | -897.37% | $17.8 / $0.25 | $-0.8 |
| 4. | Marker Therapeutics, Inc. | $1.67 | — | $27.84 M | — | -74.05% | -68.81% | $4.07 / $0.81 | $1.01 |
| 5. | Alpha Cognition Inc. Common Stock | $6.89 | — | $150.02 M | — | -23.03% | -40.68% | $11.54 / $3.97 | $2.88 |
| 6. | Crinetics Pharmaceuticals, Inc. | $40.25 | — | $4.21 B | — | -49.63% | -40.17% | $57.99 / $25.83 | $10.38 |
| 7. | Unicycive Therapeutics, Inc. | $7.43 | — | $177.17 M | — | -97.75% | -1.41% | $11 / $3.71 | $1.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -4.38 M | -6.59 M | -9.55 M | -6.76 M | -2.21 M |
| Net Profit | -6.76 M | -7.1 M | -9.52 M | -6.66 M | -2.16 M |
| EPS in Rs | -0.11 | -0.11 | -0.15 | -0.1 | -0.03 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -27.29 M | -17.15 M | -13.17 M | -9.72 M |
| Net Profit | -30.05 M | -21.68 M | -29.32 M | -9.37 M |
| EPS in Rs | -0.47 | -0.34 | -0.46 | -0.15 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 27.35 M | 19.97 M | 4.36 M | 15.2 M |
| Total Liabilities | 6.42 M | 5.37 M | 5.92 M | 2.89 M |
| Equity | 20.93 M | 14.59 M | -1.56 M | 12.3 M |
| Current Assets | 4.62 M | 19.61 M | 4.16 M | 14.74 M |
| Current Liabilities | 5.92 M | 5.33 M | 3.6 M | 2.87 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -27.63 M | -14.73 M | -11.95 M | -7.51 M |
| Investing CF | -1.34 M | -6.05 M | -1.3 M | -0.04 M |
| Financing CF | 19.93 M | 29.77 M | 2.66 M | 16.25 M |
| Free CF | -27.71 M | -14.79 M | -12.03 M | -7.54 M |
| Capex | -0.08 M | -0.06 M | -0.08 M | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 26.04% | -212.96% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-10-18 | 1:0.0285714 |
| 2022-11-14 | 1:0.02 |